menu search

Maxcyte to report first quarter 2023 financial results on may 10, 2023

ROCKVILLE, Md., April 12, 2023 (GLOBE NEWSWIRE) -- Maxcyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading,...

April 12, 2023, 4:05 pm

Humacyte (huma) completes enrollment in hav technology study

Humacyte (HUMA) surges as it completes patient enrollment in a late-stage clinical study on the human a...

April 12, 2023, 2:25 pm

Broadwood partners now owns 33.3% of oncocyte

Fintel reports that Broadwood Partners has filed a 13D/A form with the SEC disclosing ownership of 57.13MM shares of Onco...

April 10, 2023, 10:23 pm

Incyte (incy) down 9.6% so far in 2023 on recent setbacks

Incyte (INCY) shares are down 9.6% in the year so far on pipeline setbacks....

April 5, 2023, 6:15 pm

Sutro biopharma reports full year 2022 financial results, business highlights and select anticipated milestones

– Sutro plans to initiate a Phase 2/3 registration-directed study of luvelta for patients with platinum resistant ovarian cancer in the second quart...

March 30, 2023, 8:30 pm

Incyte's (incy) pemazyre gets approval to treat mlns in japan

Incyte (INCY) receives approval for treating myeloid or lymphoid neoplasms using Pemazyre (pemigatinib)...

March 27, 2023, 1:45 pm

Fda rejection pushes incyte stock sharply lower

The shares of Incyte Corporation   ( NASDAQ:INCY) are down 5.3% at $68.33 at last check, after the U.S...

March 24, 2023, 11:05 am

Humacyte, inc. (huma) reports q4 loss, misses revenue estimates

Humacyte, Inc. (HUMA) delivered earnings and revenue surprises of 12.50% and 100%, respectively, for th...

March 24, 2023, 9:57 am

Incyte stock dives on surprise rejection for updated jakafi

Incyte stock toppled Friday after the FDA unexpectedly rejected an extended-release version of its bloc...

March 24, 2023, 9:17 am

Incyte (incy) gets crl for jakafi extended-release tablets

The FDA issues a complete response letter to Incyte's (INCY) extended-release tablet formulation of Jak...

March 24, 2023, 8:26 am

Incyte (incy) receives fda approval for skin cancer treatment

Incyte (INCY) gets accelerated approval for retifanlimab-dlwr for the treatment of adults with metastat...

March 23, 2023, 1:44 pm

Humacyte to present fourth quarter and full year financial results and provide corporate update on march 24, 2023

DURHAM, N.C., March 21, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotec...

March 21, 2023, 8:01 am

Incyte (incy) vitiligo drug povorcitinib positive in phase ii

Incyte (INCY) announces positive data on povorcitinib and Opzelura for the treatment of nonsegmental vi...

March 20, 2023, 12:59 pm

Maxcyte, inc. (mxct) q4 2022 earnings call transcript

Maxcyte, Inc. (NASDAQ:MXCT ) Q4 2022 Earnings Conference Call March 15, 2023 4:30 PM ET Company Partici...

March 15, 2023, 9:41 pm

Double-digit sales growth: is this stock a convincing buy for growth investors?

Veracyte's revenue grew at a healthy clip in the fourth quarter. The genomic test company's financial h...

March 10, 2023, 9:30 am

Cardiol therapeutics says new study results highlight the cardioprotective effects of cannabidiol

Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) said that new study results have demonstrated the cardioprotective effects of pharmaceutically manufactur...

March 7, 2023, 12:22 pm

cytek biosciences, inc. (ctkb) q4 earnings top estimates

cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 40% and 3.07%, respectively,...

February 28, 2023, 9:05 pm

Vaxcyte, inc. (pcvx) q4 2022 earnings call transcript

Vaxcyte, Inc. (NASDAQ:PCVX ) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ET Company Part...

February 27, 2023, 10:03 pm

Veracyte to participate in upcoming investor conferences

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) announced today that Marc S...

February 27, 2023, 5:00 pm

Veracyte, inc. (vcyt) q4 2022 earnings call transcript

Start Time: 16:30 January 1, 0000 5:29 PM ET Veracyte, Inc. (NASDAQ:VCYT ) Q4 2022 Earnings Conference ...

February 23, 2023, 12:13 am


Search within

Pages Search Results: